WST Financial Facts
Research and development: 9MCost of goods and services sold: 255.6M
See Full Income Statement
Investments in affiliated companies: 81.4M
Other noncurrent assets: 22.8M
See Full Balance Sheet
West Pharmaceutical Services, Inc. (WST) Earnings
|
Expand Research on WST
Next EPS Date | 4/25/24 | EPS Growth Rate | -34.3% |
---|---|---|---|
Average EPS % Beat Rate | +11.9% | Revenue Growth Rate | -6.5% |
Average % Move 1-Wk after EPS | -5.5% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
2/16/23 | Q422 | $1.77 | $1.37 | +$0.40 | $708.7M | $657.17M | = | Details | |||
7/26/18 | Q218 | $0.70 | $0.67 | +$0.03 | $447.5M | $424.49M | = | Details | |||
4/27/17 | Q117 | $0.81 | $0.55 | +$0.26 | $387.7M | $380.42M | = | Details | |||
4/23/20 | Q120 | $1.01 | $0.82 | +$0.19 | $491.5M | $466.79M | = | Details | |||
10/26/17 | Q317 | $0.67 | $0.53 | +$0.14 | $398.2M | $385.9M | = | Details | |||
7/25/19 | Q219 | $0.89 | $0.72 | +$0.17 | $469.7M | $460.4M | = | Details | |||
2/13/20 | Q419 | $0.82 | $0.72 | +$0.10 | $470.6M | $451.53M | = | Details | |||
4/25/19 | Q119 | $0.74 | $0.65 | +$0.09 | $443.5M | $430.67M | = | Details |